The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
I think about this a lot when I look at how we can better understand some of the biological targets that are driving the disease and the way that an an easier way to do that is look at some of the extremes so the folks that don't have all of the metabolic risk factors but do have pretty aggressive disease for example lean people that are sort of a a normal body habitus — and then manifest rip roaring — metabolic dysfunction including St hepatitis plus or minus fibrosis
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.